SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis

Table 4

The association between SPTBN2 expression and clinicopathologic features in the local validated cohort.

Clinicopathologic features	High expression ()	Low expression ()		value
Tumor size (mm)			2.064	0.004^a
≥20	18	8
<20	6	16
Lymph-node metastasis			12.343	<0.001^a
Yes	20	8
No	4	16
Disease stage (AJCC7)			5.371	0.020^a
I+II	9	17
III+IV	15	7

Chi-square test. ^a value < 0.05. AJCC: American Joint Committee on Cancer.